{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:20:48Z","timestamp":1780935648558,"version":"3.54.1"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,15]]},"DOI":"10.1093\/bjd\/ljad218","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T07:51:40Z","timestamp":1688370700000},"page":"362-363","source":"Crossref","is-referenced-by-count":4,"title":["Predicting progression in very thin melanoma: the challenge of the next decade?"],"prefix":"10.1093","volume":"189","author":[{"given":"Simone","family":"Ribero","sequence":"first","affiliation":[{"name":"Department of Medical Sciences, Section of Dermatology, University of Turin , Turin , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Quaglino","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Section of Dermatology, University of Turin , Turin , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Roccuzzo","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Section of Dermatology, University of Turin , Turin , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"key":"2023091515301164400_ljad218-B1","doi-asserted-by":"crossref","DOI":"10.1093\/bjd\/ljad195","article-title":"Predictors of sentinel lymph node metastasis in very thin invasive melanomas","volume":"189","author":"Kakish","year":"2023","journal-title":"Br J Dermatol"},{"key":"2023091515301164400_ljad218-B2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/phpp.12770","article-title":"Prognostic biomarkers of cutaneous melanoma","volume":"38","author":"Ding","year":"2022","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2023091515301164400_ljad218-B3","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10235475","article-title":"Clinical significance of distant metastasis-free survival (DMFS) in melanoma: a narrative review from adjuvant clinical trials","volume":"10","author":"Amabile","year":"2021","journal-title":"J Clin Med"},{"key":"2023091515301164400_ljad218-B4","doi-asserted-by":"crossref","first-page":"e21575","DOI":"10.1200\/JCO.2018.36.15_suppl.e21575","article-title":"A prognostic gene-signature based identification of high-risk thin melanomas","volume":"36","author":"Koelblinger","year":"2018","journal-title":"J Clin Oncol"},{"key":"2023091515301164400_ljad218-B5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jamadermatol.2015.2235","article-title":"Association of histologic regression in primary melanoma with sentinel lymph node status: a systematic review and meta-analysis","volume":"151","author":"Ribero","year":"2015","journal-title":"JAMA Dermatol"},{"key":"2023091515301164400_ljad218-B6","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/jnci\/djz034","article-title":"Distinct clinicopathological and prognostic features of thin nodular primary melanomas: an international study from 17 centers","volume":"111","author":"Dessinioti","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"2023091515301164400_ljad218-B7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/XCS.0000000000000088","article-title":"Treat now or treat later: comparative effectiveness of adjuvant therapy in resected stage IIIA melanoma","volume":"234","author":"Ma","year":"2022","journal-title":"J Am Coll Surg"},{"key":"2023091515301164400_ljad218-B8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S1470-2045(20)30062-0","article-title":"Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial","volume":"21","author":"Dummer","year":"2020","journal-title":"Lancet Oncol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljad218\/50997877\/ljad218.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/189\/4\/362\/51604965\/ljad218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/189\/4\/362\/51604965\/ljad218.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T08:27:11Z","timestamp":1702715231000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/189\/4\/362\/7216958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":8,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,7,3]]},"published-print":{"date-parts":[[2023,9,15]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljad218","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10]]},"published":{"date-parts":[[2023,7,3]]}}}